Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa for Anemia in MDS
NCT01039350Phase 2Terminated
- Sponsor
- Fundación para el Estudio de la Hematología y Hemoterapia en Aragón
- Start
- Feb 2006
- Primary completion
- Jul 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in myelodysplastic syndrome (MDS), sponsored by Fundación para el Estudio de la Hematología y Hemoterapia en Aragón. Started Feb 2006; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01039350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039350.